Author

Eric M. Roskelley

Observed names: E. Roskelley, Eric M Roskelley, Eric Roskelley

Observed institutions: Western Michigan University, Proteostasis Therapeutics (United States)

OpenAlex ID: A5060877658

CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy

2010 · Marco A. Passini, Jie Bu, et al. · Journal of Clinical Investigation · 292

Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity

2008 · James C Dodge, Amanda M Haidet, et al. · Molecular Therapy · 160

Timing of Therapeutic Intervention Determines Functional and Survival Outcomes in a Mouse Model of Late Infantile Batten Disease

2007 · Mario A Cabrera-Salazar, Eric M Roskelley, et al. · Molecular Therapy · 82

GDNF is regulated in an activity‐dependent manner in rat skeletal muscle

2002 · Erica A. Wehrwein, Eric M. Roskelley, et al. · Muscle & Nerve · 73

WS1.3 Enhanced correction of F508del CFTR using drug-like small molecules in combination with correctors and potentiators

2014 · J.P. Miller, L. Drew, et al. · Journal of Cystic Fibrosis

S3–02–04: Developing Usp14 inhibitors as disease‐modifying therapeutics for protein aggregation diseases

2013 · Peter Reinhart, Anjanabha Saha, et al. · Alzheimer s & Dementia

P3‐351: Small‐molecule inhibition of Usp14 enhances the proteolytic degradation and clearance of misfolded proteins associated with neurodegenerative diseases

2012 · Steve Jacobsen, Chris Conrad, et al. · Alzheimer s & Dementia

893. Second Generation Gene Therapy Vector for Classical Late Infantile Neuronal Ceroid Lipofuscinosis

2006 · Mario A. Cabrera-Salazar, Bradley L. Hodges, et al. · Molecular Therapy

Works count: 8

Citation count: 607

H-index: 4

I10-index: 4